About Possis
Possis is a Healthcare company based in Leverkusen (Germany) founded in 1996, and was acquired by Medrad in February 2008. It operates as a medical devices for coronary blockage removal are developed and marketed. Its chief executive is Robert G Dutcher. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and Transvascular and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
Possis Medical develops, manufactures, and markets medical devices for cardiovascular and vascular treatment markets. It offers AngioJet ultra thrombectomy system for thrombectomy of coronary arteries and bypass grafts, conduits for AV access, peripheral arteries, and peripheral veins and AngioJet rheolytic thrombectomy system for removing clots. Apart from these, the company also provides SafeSeal hemostasis patch and Fetch aspiration catheter, a rapid exchange catheter to remove soft embolis and thrombis. Possis medical was previously known as Possis Corporation. In 2008, Possis Medical was acquired by Bayer Healthcares division Medrad, for 361M.
- Headquarters Leverkusen, Germany
- Stage Acquired
- SectorsHealthcare
- Website possis.com
- Acquired by Medrad (Feb 2008)
Investors in Possis
Possis has secured backing from 1 investor. Prominent investors backing the company include Medrad.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Portfolio of surgical equipment for diagnostic imaging, cardiovascular surgery, anaesthesiology and critical care | 1964 | medrad.com | Warrendale, United States |
Investor details for Possis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Possis
1 people are tracked at Possis (1 in leadership).
| Name | Role | Group |
|---|---|---|
Robert G Dutcher | Chairman & CEO | Leadership |
Complete people profiles for Possis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Possis
2 dated milestones of Possis across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Possis is founded.
- Exit Acquired by Medrad.
Competitors of Possis
Possis has 10 listed competitors in our database, 9 of them funded. They include Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and Transvascular, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| silkroadmed.com | 2007 | Sunnyvale, United States | $241.8M | 352 | Provider of neuroprotection devices for carotid artery disease | |
| lifetechmed.com | 1999 | Shenzhen, China | $66.2M | 44 | Interventional devices for cardiovascular and vascular diseases are developed. | |
| hdltherapeutics.com | 2010 | Short Hills, United States | $17.79M | – | Therapy to reverse coronary atherosclerosis is developed using patient plasma. | |
| supiramedical.com | 2016 | Campbell, United States | $240.5M | – | Developer of ventricular assist devices for coronary intervention and cardiogenic shock | |
| transvascular.com | 1996 | Menlo Park, United States | $10.8M | – | A TransAccess Catheter System that is used to deliver cells to damaged portions of the heart | |
| s4medical.com | 2017 | Columbus, United States | $7.62M | – | Catheter ablation treatments for atrial fibrillation are developed. | |
| intershunt.com | 2015 | Louisiana, United States | $26.55M | – | Cardiac catheters for cardiac disease treatment are developed. | |
| avspulse.com | 2017 | Ann Arbor, United States | $70.45M | – | Pulsatile intravascular lithotripsy is developed for calcified arterial disease treatment. | |
| cardiomind.com | 2003 | Sunnyvale, United States | $75M | – | Drug-eluting stents for small coronary lesions were developed. | |
| impella.com | 1998 | Aachen, Germany | – | 840 | Ventricular assist devices are provided for cardiac hemodynamic support. |
Detailed competitors of Possis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Possis
Websites that share an audience with Possis (possis.com).
Websites whose visitors overlap most with Possis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cerus.com | 100% | 8.8K | #2,272,516 | View details | |
harlaneurope.com | harlaneurope.com | 100% | – | – | – |
| immucor.com | 100% | 2.5K | #5,047,876 | View details | |
nybloodcenter.org | nybloodcenter.org | 100% | – | – | – |
| machaondiagnostics.com | 100% | – | #2,768,798 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Possis
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as Possis (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Possis
Possis was founded in 1996.
Possis is headquartered in Leverkusen, Germany. It is registered at Leverkusen, North Rhine-westphalia, Germany.
Robert G Dutcher is the current CEO of Possis.
Possis Medical develops, manufactures, and markets medical devices for cardiovascular and vascular treatment markets. It offers AngioJet ultra thrombectomy system for thrombectomy of coronary arteries and bypass grafts, conduits for AV access, peripheral arteries, and peripheral veins and AngioJet rheolytic thrombectomy system for removing clots. Apart from these, the company also provides SafeSeal hemostasis patch and Fetch aspiration catheter, a rapid exchange catheter to remove soft embolis and thrombis. Possis medical was previously known as Possis Corporation. In 2008, Possis Medical was acquired by Bayer Healthcares division Medrad, for 361M.
Possis's top competitors include Silk Road Medical, Lifetech Scientific Corporation and InterShunt Technologies.
Possis has 1 investor. Key investors include Medrad.
Yes. Possis was acquired by Medrad in February 2008.